Trial intelligence / Profile preview

Safety and feasibility of xenon anesthesia after CABG implantation

2010-023942-63Phase 3Completed

Sponsor
Clinical Trials Center Aachen
Start
Dec 2010
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Countries
1
01

Overview

Phase 3 trial of xenon in coronary arteriosclerosis and Not applicable (2 arms), sponsored by Clinical Trials Center Aachen. Primary endpoint: Depth of anesthesia. Started Dec 2010; status: completed.

02

Drugs

xenon
03

Conditions

coronary arteriosclerosisNot applicable

Beyond the preview

Go deeper on 2010-023942-63.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023942-63.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call